Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

247
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
247
Menopause01:28

Menopause

2.3K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
2.3K
Stress and Mental Health01:30

Stress and Mental Health

261
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
261
Depression: Overview01:18

Depression: Overview

435
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
435
Anxiety: Overview01:18

Anxiety: Overview

479
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
479
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

183
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
183

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The risk of thromboembolism and use of combined oral contraceptives: a comment.

BJOG : an international journal of obstetrics and gynaecology·2023
Same author

[Contraception in Women at Risk].

Therapeutische Umschau. Revue therapeutique·2022
Same author

[Menopausal Hormone Therapy in women with other underlying diseases: how to proceed?]

Therapeutische Umschau. Revue therapeutique·2021
Same author

Therapeutische Umschau. Revue therapeutique·2021
Same author

Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.

Swiss medical weekly·2017
Same author

EMAS position statement: The ten point guide to the integral management of menopausal health.

Maturitas·2015

Related Experiment Video

Updated: Oct 19, 2025

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.9K

[Climacteric depression and anxiety].

Martin Birkhäuser1

  • 1Universität Bern.

Therapeutische Umschau. Revue Therapeutique
|September 24, 2021
PubMed
Summary

Menopausal transition increases depression risk in women, especially with vasomotor symptoms. Estrogen therapy may help early on, but antidepressants are key for elderly postmenopausal women without hot flashes.

Area of Science:

  • Reproductive Endocrinology
  • Psychiatry
  • Women's Health

Background:

  • Women experience depression twice as often as men, with a lifetime prevalence of 18-21%.
  • The menopausal transition represents a critical period, elevating depression risk by 1.5-4 times.
  • Depression during this phase is often underestimated and requires active screening by healthcare providers.

Purpose of the Study:

  • To investigate the role of hormonal changes during menopause in depression and anxiety.
  • To evaluate the efficacy of estrogen therapy and antidepressants in managing climacteric depression.
  • To highlight the need for integrated treatment approaches for menopausal depression.

Main Methods:

  • Review of existing literature on hormonal influences on mood during the menopausal transition.

More Related Videos

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

17.9K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.3K

Related Experiment Videos

Last Updated: Oct 19, 2025

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.9K
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

17.9K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.3K
  • Analysis of the effectiveness of estrogen therapy versus selective serotonin reuptake inhibitors (SSRIs)/serotonin-norepinephrine reuptake inhibitors (SNRIs) in different menopausal stages.
  • Consideration of combined therapeutic strategies including psychotherapy and social support.

    • Main Results:

    • Estrogen modulates neurotransmitters like serotonin and norepinephrine, impacting mood and cognition.
    • Estrogen therapy shows potential for improving mood and anxiety in peri- and early postmenopausal women with vasomotor symptoms.
    • Estrogen therapy is not effective for depression in late postmenopause; SSRIs/SNRIs remain first-line for elderly postmenopausal women without hot flashes.

    Conclusions:

    • Menopausal depression is a significant concern requiring proactive identification and management.
    • Hormone therapy can be a viable first-line treatment for depression in early menopausal stages, particularly with vasomotor symptoms.
    • Comprehensive treatment plans integrating pharmacotherapy, psychotherapy, and social measures are essential for optimal outcomes in climacteric depression.